(Reuters) - Laboratory Corp of America Holdings said on Thursday it would spin off its wholly owned business focused on clinical drug trials, sending its shares up nearly 4%.
The organ-on-a-chip developer Emulate has raised $82 million to boost its offerings aimed at replicating human biology through easier-to-manage in vitro cellular models.
Tempus fugit: And time especially flies when it comes clinical trials. Covance, like so many other CROs, is teaming up with the suitably named Tempus to try to clip time’s wings.
BURLINGTON, N.C.--(BUSINESS WIRE)--LabCorp® (NYSE:LH), a leading global life sciences company that is deeply integrated in guiding patient care, today introduced its focused and coordinated suite of cell and gene therapy development solutions from Covance, its drug development business. These solutions are designed to reduce time and risk for sponsors at each phase and across the full continuum of their therapy development needs in one of the industry’s fastest-growing segments.
John Ratliff’s position has changed three times this fall, but now, much like the falling leaves, he looks to have settled.
As Covance changes up its leadership amid a major change at the top of its parent company, one of its former execs has jumped ship to midsize rival CRO Pharm-Olam.
Only about 1 percent of the population is naturally ambidextrous – the ability to accomplish tasks equally well with either hand.
A small Cambridge, Massachusetts-based company is hoping its bet on CNS drugs using a well established pharmaceutical approach — allosteric modulators — will cement its place as a biotech powerhouse in the years to come. Cadent Therapeutics — currently a 9-person team — has already found a partner in Novartis $NVS.
LabCorp, a leading global life sciences company, and Unilabs, a leading European provider of clinical laboratory testing and medical diagnostic imaging services, announced a strategic collaboration to provide expanded global development and delivery of companion diagnostics. This collaboration broadens the network of laboratories used by biopharmaceutical companies to support companion diagnostic development and commercialization.
Collaboration creates global laboratory network for the development and commercialization of companion diagnostics. LabCorp® (NYSE: LH), a leading global life sciences company, and Unilabs, a leading European provider of clinical laboratory testing and medical diagnostic imaging services, announced a strategic collaboration to provide expanded global development and delivery of companion diagnostics.